Document:

Exhibit
10.39

 

THIS
INSTRUMENT AND ANY SECURITIES ISSUABLE PURSUANT HERETO HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED,
PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED IN THIS SAFE AND UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT OR AN EXEMPTION THEREFROM.

 

BIGTOKEN,
INC.

 

SAFE

(Simple
Agreement for Future Equity)

 

THIS
CERTIFIES THAT, in exchange for the payment by SRAX, Inc. (the “Investor”) of $[*] (the “Purchase Amount”)
on or about February 10, 2022, BIGtoken, Inc., a Florida corporation (the “Company”), issues to the Investor the right
to certain securities of the Company’s, subject to the terms described below.

 

The
“Discount Rate” is 80%.

 

The
“Warrant Coverage” is 100%.

 

See
Section 2 for certain additional defined terms.

 

1.
Events

 

(a)
Financing. At any time there is a Financing prior to the termination of this Safe, this Safe may be converted, at the option
of the Investor, into: (i) the number of shares of Safe Preferred Stock equal to the applicable Purchase Amount divided by the Discount
Price and (ii) Warrants to purchase such number of shares of Safe Preferred Stock equal to the applicable Purchase Amount divided by
the Discount Price. Provided that upon conversion of the Safe, in no event will the number of Warrants held by Investor exceed such number
of shares equal to the applicable Purchase Amount divided by the Discount Price.

In
connection with the conversion of this Safe into shares of Safe Preferred Stock and Warrants, the Investor will execute and deliver to
the Company all of the transaction documents related to the Financing; provided, that such documents (i) are the same documents
to be entered into with the purchasers of the Financing, with appropriate variations for the Safe Preferred Stock if applicable, and
(ii) have customary exceptions to any drag-along applicable to the Investor, including (without limitation) limited representations,
warranties, liability and indemnification obligations for the Investor.

 

(b)
Liquidity Event. If there is a Liquidity Event before the termination of this Safe, this Safe will automatically be entitled
(subject to the liquidation priority set forth in Section 1(d) below) to receive a portion of Proceeds, due and payable to the Investor
immediately prior to, or concurrent with, the consummation of such Liquidity Event, equal to, at the election of the Investor, the greater
of (i) the Purchase Amount (the “Cash-Out Amount”), (ii) the amount payable on the number of shares of Common Stock
equal to the Purchase Amount divided by the Discount Price or (iii) such number of shares of Safe Preferred Stock and Warrants equal
to the Purchase Amount divided by the Discount Price (the “Conversion Amount”). If any of the Company’s securityholders
are given a choice as to the form and amount of Proceeds to be received in a Liquidity Event, the Investor will be given the same choice,
provided that the Investor may not choose to receive a form of consideration that the Investor would be ineligible to receive
as a result of the Investor’s failure to satisfy any requirement or limitation generally applicable to the Company’s securityholders,
or under any applicable laws.

 

Notwithstanding
the foregoing, in connection with a Change of Control intended to qualify as a tax-free reorganization, the Company may reduce the cash
portion of Proceeds payable to the Investor by the amount determined by its board of directors in good faith for such Change of Control
to qualify as a tax-free reorganization for U.S. federal income tax purposes, provided that such reduction (A) does not reduce the total
Proceeds payable to such Investor and (B) is applied in the same manner and on a pro rata basis to all securityholders who have equal
priority to the Investor under Section 1(d).

 

    	 

     

    

 

(c)
Dissolution Event. If there is a Dissolution Event before the termination of this Safe, the Investor will automatically
be entitled (subject to the liquidation priority set forth in Section 1(d) below) to receive a portion of Proceeds equal to the Cash-Out
Amount, due and payable to the Investor immediately prior to the consummation of the Dissolution Event.

 

(d)
Liquidation Priority. In a Liquidity Event or Dissolution Event, this Safe is intended to operate like standard non-participating
Preferred Stock. The Investor’s right to receive its Cash-Out Amount is:

 

(i)
Junior to payment of outstanding indebtedness and creditor claims, including contractual claims for payment and convertible promissory
notes (to the extent such convertible promissory notes are not actually or notionally converted into Capital Stock);

 

(ii)
On par with payments for other Safes and/or Preferred Stock, and if the applicable Proceeds are insufficient to permit full payments
to the Investor and such other Safes and/or Preferred Stock, the applicable Proceeds will be distributed pro rata to the Investor and
such other Safes and/or Preferred Stock in proportion to the full payments that would otherwise be due; and

 

(iii)
Senior to payments for Common Stock.

 

The
Investor’s right to receive its Conversion Amount is (A) on par with payments for Common Stock and other Safes and/or Preferred
Stock who are also receiving Conversion Amounts or Proceeds on a similar as-converted to Common Stock basis, and (B) junior to payments
described in clauses (i) and (ii) above (in the latter case, to the extent such payments are Cash-Out Amounts or similar liquidation
preferences).

 

(e)
Termination. This Safe will automatically terminate (without relieving the Company of any obligations arising from a prior
breach of or non-compliance with this Safe) immediately following the earliest to occur of: (i) the issuance of all Safe Preferred Stock
to the Investor pursuant to the conversion of the entire Purchase Price of this Safe under Section 1(a); or (ii) the payment, or setting
aside for payment, of amounts due the Investor pursuant to Section 1(b) or Section 1(c).

 

2.
Definitions

 

“Capital
Stock” means the capital stock of the Company, including, without limitation, the “Common Stock” and the
“Preferred Stock.”

 

“Change
of Control” means (i) a transaction or series of related transactions in which any “person” or “group”
(within the meaning of Section 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended), becomes the “beneficial owner”
(as defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended), directly or indirectly, of more than 50% of the outstanding
voting securities of the Company having the right to vote for the election of members of the Company’s board of directors, (ii)
any reorganization, merger or consolidation of the Company, other than a transaction or series of related transactions in which the holders
of the voting securities of the Company outstanding immediately prior to such transaction or series of related transactions retain, immediately
after such transaction or series of related transactions, at least a majority of the total voting power represented by the outstanding
voting securities of the Company or such other surviving or resulting entity or (iii) a sale, lease or other disposition of all or substantially
all of the assets of the Company.

 

“Convertible
Securities” includes this Safe and other convertible securities issued by the Company, including but not limited to: (i) other
Safes; (ii) convertible promissory notes and other convertible debt instruments; and (iii) convertible securities that have the right
to convert into shares of Capital Stock.

 

“Discount
Price” means the Lowest price per share of equity securities sold in any Financing (prior to the termination of this Safe)
multiplied by the Discount Rate.

 

    	-2-

     

    

 

“Dissolution
Event” means (i) a voluntary termination of operations, (ii) a general assignment for the benefit of the Company’s creditors
or (iii) any other liquidation, dissolution or winding up of the Company (excluding a Liquidity Event), whether voluntary
or involuntary.

 

“Financing”
means a bona fide transaction or series of transactions with the principal purpose of raising capital, pursuant to which the Company
issues securities.

 

“Liquidity
Event” means a Change of Control or the listing of the Company’s Capital Stock on a National Securities Exchange.

 

“National
Securities Exchange” means a securities exchange that has registered with the SEC under Section 6 of the Securities Exchange
Act of 1934.

 

“Options”
includes options, restricted stock awards or purchases, RSUs, SARs, warrants or similar securities, vested or unvested.

 

“Proceeds”
means cash and other assets (including without limitation stock consideration) that are proceeds from the Liquidity Event or the Dissolution
Event, as applicable, and legally available for distribution.

 

“Promised
Options” means promised but ungranted Options that are the greater of those (i) promised pursuant to agreements or understandings
made prior to the execution of, or in connection with, the term sheet or letter of intent for the Financing or Liquidity Event, as applicable
(or the closing of any Financing or consummation of the Liquidity Event, if there is no term sheet or letter of intent), (ii) in the
case of an Financing, treated as outstanding Options in the calculation of the Standard Preferred Stock’s price per share, or (iii)
in the case of a Liquidity Event, treated as outstanding Options in the calculation of the distribution of the Proceeds.

 

“Safe”
means an instrument containing a future right to shares of Capital Stock or Convertible Securities, similar in form and content to this
instrument, purchased by investors for the purpose of funding the Company’s business operations. References to “this Safe”
mean this specific instrument.

 

“Safe
Preferred Stock” means the shares of non-voting Series D Preferred Stock issued to the Investor in an Equity Financing, having
the identical rights, privileges, preferences and restrictions as contained in the certificate of designation attached hereto as Exhibit
A.

 

“SEC”
means the United States Securities and Exchange Commission.

 

“Unissued
Option Pool” means all shares of Capital Stock that are reserved, available for future grant and not subject to any outstanding
Options or Promised Options (but in the case of a Liquidity Event, only to the extent Proceeds are payable on such Promised Options)
under any equity incentive or similar Company plan.

 

“Warrant”
means a warrant to purchase such number of shares of Safe Preferred Stock equal to the applicable Purchase Amount divided by the
Discount Price. The Warrant will have: (i) an exercise price equal to the Discount Price, (ii) price protection, but will not result
in additional shares underlying the Warrant, and (iii) a term of 5 years.

 

    	-3-

     

    

 

3.
Company Representations

 

(a)
The Company is a corporation duly organized, validly existing and in good standing under the laws of its state of incorporation, and
has the power and authority to own, lease and operate its properties and carry on its business as now conducted.

 

(b)
The execution, delivery and performance by the Company of this Safe is within the power of the Company and has been duly authorized by
all necessary actions on the part of the Company (subject to section 3(d)). This Safe constitutes a legal, valid and binding obligation
of the Company, enforceable against the Company in accordance with its terms, except as limited by bankruptcy, insolvency or other laws
of general application relating to or affecting the enforcement of creditors’ rights generally and general principles of equity.
To its knowledge, the Company is not in violation of (i) its current certificate of incorporation or bylaws, (ii) any material statute,
rule or regulation applicable to the Company or (iii) any material debt or contract to which the Company is a party or by which it is
bound, where, in each case, such violation or default, individually, or together with all such violations or defaults, could reasonably
be expected to have a material adverse effect on the Company.

 

(c)
The performance and consummation of the transactions contemplated by this Safe do not and will not: (i) violate any material judgment,
statute, rule or regulation applicable to the Company; (ii) result in the acceleration of any material debt or contract to which the
Company is a party or by which it is bound; or (iii) result in the creation or imposition of any lien on any property, asset or revenue
of the Company or the suspension, forfeiture, or nonrenewal of any material permit, license or authorization applicable to the Company,
its business or operations.

 

(d)
No consents or approvals are required in connection with the performance of this Safe, other than: (i) the Company’s corporate
approvals; (ii) any qualifications or filings under applicable securities laws; and (iii) necessary corporate approvals for the authorization
of Capital Stock issuable pursuant to Section 1.

 

(e)
To its knowledge, the Company owns or possesses (or can obtain on commercially reasonable terms) sufficient legal rights to all patents,
trademarks, service marks, trade names, copyrights, trade secrets, licenses, information, processes and other intellectual property rights
necessary for its business as now conducted and as currently proposed to be conducted, without any conflict with, or infringement of
the rights of, others.

 

4.
Investor Representations

 

(a)
The Investor has full legal capacity, power and authority to execute and deliver this Safe and to perform its obligations hereunder.
This Safe constitutes valid and binding obligation of the Investor, enforceable in accordance with its terms, except as limited by bankruptcy,
insolvency or other laws of general application relating to or affecting the enforcement of creditors’ rights generally and general
principles of equity.

 

(b)
The Investor is an accredited investor as such term is defined in Rule 501 of Regulation D under the Securities Act, and acknowledges
and agrees that if not an accredited investor at the time of an Equity Financing, the Company may void this Safe and return the Purchase
Amount. The Investor has been advised that this Safe and the underlying securities have not been registered under the Securities Act,
or any state securities laws and, therefore, cannot be resold unless they are registered under the Securities Act and applicable state
securities laws or unless an exemption from such registration requirements is available. The Investor is purchasing this Safe and the
securities to be acquired by the Investor hereunder for its own account for investment, not as a nominee or agent, and not with a view
to, or for resale in connection with, the distribution thereof, and the Investor has no present intention of selling, granting any participation
in, or otherwise distributing the same. The Investor has such knowledge and experience in financial and business matters that the Investor
is capable of evaluating the merits and risks of such investment, is able to incur a complete loss of such investment without impairing
the Investor’s financial condition and is able to bear the economic risk of such investment for an indefinite period of time.

 

    	-4-

     

    

 

5.
Miscellaneous

 

(a)
Any provision of this Safe may be amended, waived or modified by written consent of the Company and the Investor.

(b)
Any notice required or permitted by this Safe will be deemed sufficient when delivered personally or by overnight courier or sent by
email to the relevant address listed on the signature page, or 48 hours after being deposited in the U.S. mail as certified or registered
mail with postage prepaid, addressed to the party to be notified at such party’s address listed on the signature page, as subsequently
modified by written notice.

 

(c)
The Investor is not entitled, as a holder of this Safe, to vote or be deemed a holder of Capital Stock for any purpose other than tax
purposes, nor will anything in this Safe be construed to confer on the Investor, as such, any rights of a Company stockholder or rights
to vote for the election of directors or on any matter submitted to Company stockholders, or to give or withhold consent to any corporate
action or to receive notice of meetings, until shares have been issued on the terms described in Section 1.

 

(d)
Neither this Safe nor the rights in this Safe are transferable or assignable, by operation of law or otherwise, by either party without
the prior written consent of the other; provided, however, that this Safe and/or its rights may be assigned without the Company’s
consent by the Investor (i) to the Investor’s estate, heirs, executors, administrators, guardians
and/or successors in the event of Investor’s death or disability, or (ii) to any other entity who directly or indirectly,
controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing
member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more
general partners or managing members of, or shares the same management company with, the Investor; and provided, further, that
the Company may assign this Safe in whole, without the consent of the Investor, in connection with a reincorporation to change the Company’s
domicile.

 

(e) In
the event any one or more of the provisions of this Safe is for any reason held to be invalid, illegal or unenforceable, in whole or
in part or in any respect, or in the event that any one or more of the provisions of this Safe operate or would prospectively
operate to invalidate this Safe, then and in any such event, such provision(s) only will be deemed null and void and will not affect
any other provision of this Safe and the remaining provisions of this Safe will remain operative and in full force and effect and
will not be affected, prejudiced, or disturbed thereby.

 

(f)
All rights and obligations hereunder will be governed by the laws of the State of California, without regard to the conflicts of law
provisions of such jurisdiction.

 

(g)
The parties acknowledge and agree that for United States federal and state income tax purposes this Safe is, and at all times has been,
intended to be characterized as stock, and more particularly as common stock for purposes of Sections 304, 305, 306, 354, 368, 1036 and
1202 of the Internal Revenue Code of 1986, as amended. Accordingly, the parties agree to treat this Safe consistent with the foregoing
intent for all United States federal and state income tax purposes (including, without limitation, on their respective tax returns or
other informational statements).

 

(Signature
page follows)

 

    	-5-

     

    

 

IN
WITNESS WHEREOF, the undersigned have caused this Safe to be duly executed and delivered.

 

	 	BIGTOKEN, INC.
	 	 
	 	By:	 
	 	 	David J. Moore
	 	 	CEO
	 	 	 
	 	Address:
	 	 
	 	Email:
	 	 
	 	INVESTOR:
	 	 
	 	By:	SRAX,
    Inc.
	 	Name:	Michael Malone	 
	 	Title:	CFO	 

 

	 	Address:	 
	 	 
	 	Email:hlco_ex1014.htm

EXHIBIT 10.14
  
 THE HEALING COMPANY, INC. CONSULTING AGREEMENT
   
 This Consulting Agreement (this “Agreement”) is made and entered into as of August 1, 2022 (the “Effective Date”) by and between The Healing Company, Inc., a Nevada corporation with its principal place of business at 711 S. Carson Street, Suite 4, Carson City, Nevada 89701 (the “Company”), and RayRos Holdings, LLC, a Connecticut Limited Liability Company with a principal place of business at 162 East Elm St., Greenwich CT 06830 (“Consultant”) (each herein referred to individually as a “Party,” or collectively as the “Parties”).
  
 The Company desires to retain Consultant as an independent contractor to perform consulting services for the Company, and Consultant is willing to perform such services, on the terms described below. In consideration of the mutual promises contained herein, the Parties agree as follows:
  
 1. Services and Compensation. Consultant shall perform the services described in Exhibit A (the “Services”) for the Company (or its designee), and the Company agrees to pay Consultant the compensation described in Exhibit A for Consultant’s performance of the Services. Consultant shall initially hold the role of “Head of Business Development” for the Company.
  
 2. Confidentiality.
  
 A. Definition of Confidential Information. “Confidential Information” means any information (including any and all combinations of individual items of information) that relates to the actual or anticipated business and/or products, research or development of the Company, its affiliates or subsidiaries, or to the Company’s, its affiliates’ or subsidiaries’ technical data, trade secrets, or know-how, including, but not limited to, research, product plans, or other information regarding the Company’s, its affiliates’ or subsidiaries’ products or services and markets therefor, customer lists and customers (including, but not limited to, customers of the Company on whom Consultant called or with whom Consultant became acquainted during the term of this Agreement), software, developments, inventions, discoveries, ideas, processes, formulas, technology, designs, drawings, engineering, hardware configuration information, marketing, finances, and other business information disclosed by the Company, its affiliates or subsidiaries, either directly or indirectly, in writing, orally or by drawings or inspection of premises, parts, equipment, or other property of Company, its affiliates or subsidiaries. Notwithstanding the foregoing, Confidential Information shall not include any such information which Consultant can establish: (i) was publicly known or made generally available prior to the time of disclosure to Consultant; (ii) becomes publicly known or made generally available after disclosure to Consultant through no wrongful action or inaction of Consultant; or (iii) is in the rightful possession of Consultant, without confidentiality obligations, at the time of disclosure as shown by Consultant’s then-contemporaneous written records; provided that any combination of individual items of information shall not be deemed to be within any of the foregoing exceptions merely because one or more of the individual items are within such exception, unless the combination as a whole is within such exception.
  
  	 
	-1-
	

	 

 
  
 B. Nonuse and Nondisclosure. During and after the term of this Agreement, Consultant will hold in the strictest confidence, and take all reasonable precautions to prevent any unauthorized use or disclosure of Confidential Information, and Consultant will not (i) use the Confidential Information for any purpose whatsoever other than as necessary for the performance of the Services on behalf of the Company, or (ii) subject to Consultant’s right to engage in Protected Activity (as defined below), disclose the Confidential Information to any third party without the prior written consent of an authorized representative of the Company, except that Consultant may disclose Confidential Information to the extent compelled by applicable law; provided however, prior to such disclosure, Consultant shall provide prior written notice to Company and seek a protective order or such similar confidential protection as may be available under applicable law. Consultant agrees that no ownership of Confidential Information is conveyed to the Consultant. Without limiting the foregoing, Consultant shall not use or disclose any Company property, intellectual property rights, trade secrets or other proprietary know-how of the Company to invent, author, make, develop, design, or otherwise enable others to invent, author, make, develop, or design identical or substantially similar designs as those developed under this Agreement for any third party. Consultant agrees that Consultant’s obligations under this Section 2.B shall continue after the termination of this Agreement.
  
 C. Other Client Confidential Information. Consultant agrees that Consultant will not improperly use, disclose, or induce the Company to use any proprietary information or trade secrets of any former or current employer of Consultant or other person or entity with which Consultant has an obligation to keep in confidence. Consultant also agrees that Consultant will not bring onto the Company’s premises or transfer onto the Company’s technology systems any unpublished document, proprietary information, or trade secrets belonging to any third party unless disclosure to, and use by, the Company has been consented to in writing by such third party.
  
 D. Third Party Confidential Information. Consultant recognizes that the Company has received, and in the future will receive from third parties their confidential or proprietary information subject to a duty on the Company’s part to maintain the confidentiality of such information and to use it only for certain limited purposes. Consultant agrees that at all times during the term of this Agreement and thereafter, Consultant owes the Company and such third parties a duty to hold all such confidential or proprietary information in the strictest confidence and not to use it or to disclose it to any person, firm, corporation, or other third party except as necessary in carrying out the Services for the Company consistent with the Company’s agreement with such third party.
  
 3. Ownership.
  
 A. Assignment of Inventions. Consultant agrees that all right, title, and interest in and to any copyrightable material, notes, records, drawings, designs, inventions, improvements, developments, discoveries, ideas and trade secrets conceived, discovered, authored, invented, developed or reduced to practice by Consultant, solely or in collaboration with others, during the term of this Agreement and arising out of, or in connection with, performing the Services under this Agreement and any copyrights, patents, trade secrets, mask work rights or other intellectual property rights relating to the foregoing (collectively, “Inventions”), are the sole property of the Company. Consultant also agrees to promptly make full written disclosure to the Company of any Inventions and to deliver and assign (or cause to be assigned) and hereby irrevocably assigns fully to the Company all right, title and interest in and to the Inventions.
  
  	 
	-2-
	

	 

 
  
 B. Pre-Existing Materials. Subject to Section 3.A, Consultant will provide the Company with prior written notice if, in the course of performing the Services, Consultant incorporates into any Invention or utilizes in the performance of the Services any invention, discovery, idea, original works of authorship, development, improvements, trade secret, concept, or other proprietary information or intellectual property right owned by Consultant or in which Consultant has an interest, prior to, or separate from, performing the Services under this Agreement (“Prior Inventions”), and the Company is hereby granted a nonexclusive, royaltyfree, perpetual, irrevocable, transferable, worldwide license (with the right to grant and authorize sublicenses) to make, have made, use, import, offer for sale, sell, reproduce, distribute, modify, adapt, prepare derivative works of, display, perform, and otherwise exploit such Prior Inventions, without restriction, including, without limitation, as part of or in connection with such Invention, and to practice any method related thereto. Consultant will not incorporate any invention, discovery, idea, original works of authorship, development, improvements, trade secret, concept, or other proprietary information or intellectual property right owned by any third party into any Invention without Company’s prior written permission, including without limitation any free software or open source software.
  
 C. Moral Rights. Any assignment to the Company of Inventions includes all rights of attribution, paternity, integrity, modification, disclosure and withdrawal, and any other rights throughout the world that may be known as or referred to as “moral rights,” “artist’s rights,” “droit moral,” or the like (collectively, “Moral Rights”). To the extent that Moral Rights cannot be assigned under applicable law, Consultant hereby waives and agrees not to enforce any and all Moral Rights, including, without limitation, any limitation on subsequent modification, to the extent permitted under applicable law.
  
 D. Maintenance of Records. Consultant agrees to keep and maintain adequate, current, accurate, and authentic written records of all Inventions made by Consultant (solely or jointly with others) during the term of this Agreement, and for a period of three (3) years thereafter. The records will be in the form of notes, sketches, drawings, electronic files, reports, or any other format that is customary in the industry and/or otherwise specified by the Company. Such records are and remain the sole property of the Company at all times and upon Company’s request, Consultant shall deliver (or cause to be delivered) the same.
  
 E. Further Assurances. Consultant agrees to assist Company, or its designee, at the Company’s expense, in every proper way to secure the Company’s rights in Inventions in any and all countries, including the disclosure to the Company of all pertinent information and data with respect thereto, the execution of all applications, specifications, oaths, assignments and all other instruments that the Company may deem necessary in order to apply for, register, obtain, maintain, defend, and enforce such rights, and in order to deliver, assign and convey to the Company, its successors, assigns and nominees the sole and exclusive right, title, and interest in and to all Inventions and testifying in a suit or other proceeding relating to such Inventions. Consultant further agrees that Consultant’s obligations under this Section 3.E shall continue after the termination of this Agreement.
  
  	 
	-3-
	

	 

 
  
 F. Attorney-in-Fact. Consultant agrees that, if the Company is unable because of Consultant’s unavailability, dissolution, mental or physical incapacity, or for any other reason, to secure Consultant’s signature with respect to any Inventions, including, without limitation, for the purpose of applying for or pursuing any application for any United States or foreign patents or mask work or copyright registrations covering the Inventions assigned to the Company in Section 3.A, then Consultant hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as Consultant’s agent and attorney-in-fact, to act for and on Consultant’s behalf to execute and file any papers and oaths and to do all other lawfully permitted acts with respect to such Inventions to further the prosecution and issuance of patents, copyright and mask work registrations with the same legal force and effect as if executed by Consultant. This power of attorney shall be deemed coupled with an interest, and shall be irrevocable.
  
 4. Conflicting Obligations. Consultant represents and warrants that Consultant has no agreements, relationships, or commitments to any other person or entity that conflict with the provisions of this Agreement, Consultant’s obligations to the Company under this Agreement, and/or Consultant’s ability to perform the Services. Consultant will not enter into any such conflicting agreement during the term of this Agreement.
  
 5. Return of Company Materials. Upon the termination of this Agreement, or upon Company’s earlier request, Consultant will immediately deliver to the Company, and will not keep in Consultant’s possession, recreate, or deliver to anyone else, any and all Company property, including, but not limited to, Confidential Information, tangible embodiments of the Inventions, all devices and equipment belonging to the Company, all electronically-stored information and passwords to access such property, those records maintained pursuant to Section 3.D and any reproductions of any of the foregoing items that Consultant may have in Consultant’s possession or control.
  
 6. Term and Termination.
  
 A. Term. The term of this Agreement will begin on the Effective Date of this Agreement and will continue (i) for an initial term of three (3) months (“Initial Term”) unless earlier terminated as provided in Section 6.B. Upon expiration of the Initial Term, this Agreement shall automatically renew for successive three (3) month terms (each, a “Renewal Term”) unless either Party provides written notice to the other Party of non-renewal at least thirty (30) days prior to the end of the then-current Renewal Term or unless earlier terminated as provided in Section 6.B. The Initial Term and any Renewal Terms shall be collectively referred to as the “Term”.
  
 B. Termination. Either Party may terminate this Agreement for any reason upon giving the other Party thirty (30) days prior written notice of such termination pursuant to Section 12.G of this Agreement. The Company may terminate this Agreement immediately and without prior notice if Consultant refuses to or is unable to perform the Services or is in breach of any material provision of this Agreement.
  
  	 
	-4-
	

	 

 
  
 C. Survival. Upon any termination, all rights and duties of the Company and Consultant toward each other shall cease except:
  
 (1) The Company will pay, within thirty (30) days after the effective date of termination, all amounts owing to Consultant for Services completed and accepted by the Company prior to the termination date and related reimbursable expenses, if any, submitted in accordance with the Company’s policies and in accordance with the provisions of Section 1 of this Agreement; and
  
 (2) Section 2 (Confidentiality), Section 3 (Ownership), Section 4 (Conflicting Obligations), Section 5 (Return of Company Materials), Section 6 (Term and Termination), Section 7 (Independent Contractor; Benefits), Section 8 (Indemnification), Section 9 (Non-solicitation), Section 10 (Limitation of Liability), Section 11 (Arbitration and Equitable Relief), and Section 12 (Miscellaneous) will survive termination or expiration of this Agreement in accordance with their terms.
  
 7. Independent Contractor; Benefits.
  
 A. Independent Contractor. It is the express intention of the Company and Consultant that Consultant perform the Services as an independent contractor to the Company. Nothing in this Agreement shall in any way be construed to constitute Consultant as an agent, employee or representative of the Company. Without limiting the generality of the foregoing, Consultant is not authorized to bind the Company to any liability or obligation or to represent that Consultant has any such authority. Consultant agrees to furnish (or reimburse the Company for) all tools and materials necessary to accomplish this Agreement and shall incur all expenses associated with performance. Consultant acknowledges and agrees that Consultant is obligated to report as income all compensation received by Consultant pursuant to this Agreement. Consultant agrees to and acknowledges the obligation to pay all self-employment and other taxes on such income.
  
 B. Benefits. The Company and Consultant agree that Consultant will receive no Company-sponsored benefits from the Company where benefits include, but are not limited to, paid vacation, sick leave, medical insurance and 401k participation. If Consultant is reclassified by a state or federal agency or court as the Company’s employee, Consultant will become a reclassified employee and will receive no benefits from the Company, except those mandated by state or federal law, even if by the terms of the Company’s benefit plans or programs of the Company in effect at the time of such reclassification, Consultant would otherwise be eligible for such benefits.
  
 8. Indemnification.
  
 A. Indemnification of Consultant. Company agrees to indemnify and hold harmless Consultant and its officers and employees from and against all losses, claims, damages, liabilities, judgments, costs and expenses, including attorneys’ fees and other legal expenses in connection with defending Consultant in any litigation, whether commenced or threatened, in connection with any claim, action or proceeding to which Consultant becomes subject, whether or not resulting in any liability, caused by, arising out of any Services provided the Company by the Consultant under this Agreement; provided, however, that the Company shall not be liable in any such case to the extent that any such loss, claim, or liability is found to have resulted from the negligence, bad faith, fraud or misconduct of Consultant or Consultant’s assistants, employees, contractors or agents.
  
  	 
	-5-
	

	 

 
  
 B. Indemnification of Company. Consultant agrees to indemnify and hold harmless the Company and its affiliates and their directors, officers and employees from and against all taxes, losses, damages, liabilities, costs and expenses, including attorneys’ fees and other legal expenses, arising directly or indirectly from or in connection with (i) any negligent, reckless or intentionally wrongful act of Consultant or Consultant’s assistants, employees, contractors or agents, (ii) a determination by a court or agency that the Consultant is not an independent contractor, (iii) any breach by the Consultant or Consultant’s assistants, employees, contractors or agents of any of the covenants contained in this Agreement and corresponding Confidential Information and Invention Assignment Agreement, (iv) any failure of Consultant to perform the Services in accordance with all applicable laws, rules and regulations, or (v) any violation or claimed violation of a third party’s rights resulting in whole, or in part, from the Company’s use of the Inventions or other deliverables of Consultant under this Agreement.
  
 9. Nonsolicitation. To the fullest extent permitted under applicable law, from the date of this Agreement until twelve (12) months after the termination of this Agreement for any reason (the “Restricted Period”), Consultant will not, without the Company’s prior written consent, directly or indirectly, solicit any of the Company’s employees to leave their employment, or attempt to solicit employees of the Company, either for Consultant or for any other person or entity. Consultant agrees that nothing in this Section 9 shall affect Consultant’s continuing obligations under this Agreement during and after this twelve (12) month period, including, without limitation, Consultant’s obligations under Section 2.
  
 10. Limitation of Liability. IN NO EVENT SHALL COMPANY BE LIABLE TO CONSULTANT OR TO ANY OTHER PARTY FOR ANY INDIRECT, INCIDENTAL, SPECIAL OR CONSEQUENTIAL DAMAGES, OR DAMAGES FOR LOST PROFITS OR LOSS OF BUSINESS, HOWEVER CAUSED AND UNDER ANY THEORY OF LIABILITY, WHETHER BASED IN CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHER THEORY OF LIABILITY, REGARDLESS OF WHETHER COMPANY WAS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY. IN NO EVENT SHALL COMPANY’S LIABILITY ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT EXCEED THE AMOUNTS PAID BY COMPANY TO CONSULTANT UNDER THIS AGREEMENT FOR THE SERVICES, DELIVERABLES OR INVENTION GIVING RISE TO SUCH LIABILITY.
  
 11. Arbitration and Equitable Relief.
  
 A. Arbitration. IN CONSIDERATION OF CONSULTANT’S CONSULTING RELATIONSHIP WITH THE COMPANY, ITS PROMISE TO ARBITRATE ALL DISPUTES RELATED TO CONSULTANT’S CONSULTING RELATIONSHIP WITH THE COMPANY AND CONSULTANT’S RECEIPT OF THE COMPENSATION AND OTHER BENEFITS PAID TO CONSULTANT BY COMPANY, AT PRESENT AND IN THE FUTURE, CONSULTANT AGREES THAT ANY AND ALL CONTROVERSIES, CLAIMS, OR DISPUTES WITH ANYONE (INCLUDING COMPANY AND ANY EMPLOYEE, OFFICER, DIRECTOR, SHAREHOLDER OR BENEFIT PLAN OF THE COMPANY IN THEIR CAPACITY AS SUCH OR OTHERWISE), ARISING OUT OF, RELATING TO, OR RESULTING FROM CONSULTANT’S CONSULTING OR OTHER RELATIONSHIP WITH THE COMPANY OR THE TERMINATION OF CONSULTANT’S CONSULTING OR OTHER RELATIONSHIP WITH THE COMPANY, INCLUDING ANY BREACH OF THIS AGREEMENT, SHALL BE SUBJECT TO BINDING ARBITRATION UNDER THE FEDERAL ARBITRATION ACT AND PURSUANT TO THE ARBITRATION PROVISIONS SET FORTH IN NEVADA RULES OF CIVIL PROCEDURE (THE “NRCP ACT”) AND PURSUANT TO NEVADA LAW. CONSULTANT MAY BRING A PROCEEDING AS A PRIVATE ATTORNEY GENERAL AS PERMITTED BY LAW. THE FEDERAL ARBITRATION ACT GOVERNS THIS AGREEMENT AND SHALL CONTINUE TO APPLY WITH FULL FORCE AND EFFECT NOTWITHSTANDING THE APPLICATION OF PROCEDURAL RULES SET FORTH IN THE NRCP ACT AND NEVADA LAW. CONSULTANT AGREES TO ARBITRATE ANY AND ALL COMMON LAW AND/OR STATUTORY CLAIMS UNDER LOCAL, STATE, OR FEDERAL LAW, INCLUDING, BUT NOT LIMITED TO, CLAIMS UNDER THE NEVADA LABOR LAWS, CLAIMS RELATING TO EMPLOYMENT OR INDEPENDENT CONTRACTOR STATUS, CLASSIFICATION, AND RELATIONSHIP WITH THE COMPANY, AND CLAIMS OF BREACH OF CONTRACT, EXCEPT AS PROHIBITED BY LAW. CONSULTANT ALSO AGREES TO ARBITRATE ANY AND ALL DISPUTES ARISING OUT OF OR RELATING TO THE INTERPRETATION OR APPLICATION OF THIS AGREEMENT TO ARBITRATE, BUT NOT TO DISPUTES ABOUT THE ENFORCEABILITY, REVOCABILITY OR VALIDITY OF THIS AGREEMENT TO ARBITRATE OR ANY PORTION HEREOF OR THE CLASS, COLLECTIVE AND REPRESENTATIVE PROCEEDING WAIVER HEREIN. WITH RESPECT TO ALL SUCH CLAIMS AND DISPUTES THAT CONSULTANT AGREES TO ARBITRATE, CONSULTANT HEREBY EXPRESSLY AGREES TO WAIVE, AND DOES WAIVE, ANY RIGHT TO A TRIAL BY JURY. CONSULTANT FURTHER UNDERSTANDS THAT THIS AGREEMENT TO ARBITRATE ALSO APPLIES TO ANY DISPUTES THAT THE COMPANY MAY HAVE WITH CONSULTANT.
  
  	 
	-6-
	

	 

 
  
 B. Procedure. CONSULTANT AGREES THAT ANY ARBITRATION WILL BE ADMINISTERED BY JUDICIAL ARBITRATION & MEDIATION SERVICES, INC. (“JAMS”) PURSUANT TO ITS EMPLOYMENT ARBITRATION RULES & PROCEDURES (THE “JAMS RULES”), WHICH ARE AVAILABLE AT http://www.jamsadr.com/rules-employment-arbitration/. CONSULTANT AGREES THAT THE USE OF THE JAMS RULES DOES NOT CHANGE CONSULTANT’S CLASSIFICATION TO THAT OF AN EMPLOYEE. TO THE CONTRARY, CONSULTANT REAFFIRMS THAT CONSULTANT IS AN INDEPENDENT CONTRACTOR. CONSULTANT AGREES THAT THE ARBITRATOR SHALL HAVE THE POWER TO DECIDE ANY MOTIONS BROUGHT BY ANY PARTY TO THE ARBITRATION, INCLUDING MOTIONS FOR SUMMARY JUDGMENT AND/OR ADJUDICATION AND MOTIONS TO DISMISS AND DEMURRERS APPLYING THE STANDARDS SET FORTH UNDER THE NEVADA RULES OF CIVIL PROCEDURE. CONSULTANT AGREES THAT THE ARBITRATOR SHALL ISSUE A WRITTEN DECISION ON THE MERITS. CONSULTANT ALSO AGREES THAT THE ARBITRATOR SHALL HAVE THE POWER TO AWARD ANY REMEDIES AVAILABLE UNDER APPLICABLE LAW, AND THAT THE ARBITRATOR SHALL AWARD ATTORNEYS’ FEES AND COSTS TO THE PREVAILING PARTY WHERE PROVIDED BY APPLICABLE LAW. CONSULTANT AGREES THAT THE DECREE OR AWARD RENDERED BY THE ARBITRATOR MAY BE ENTERED AS A FINAL AND BINDING JUDGMENT IN ANY COURT HAVING JURISDICTION THEREOF. CONSULTANT AGREES THAT THE ARBITRATOR SHALL ADMINISTER AND CONDUCT ANY ARBITRATION IN ACCORDANCE WITH NEVADA LAW, INCLUDING THE NEVADA RULES OF CIVIL PROCEDURE AND THE NEVADA RULES OF EVIDENCE, AND THAT THE ARBITRATOR SHALL APPLY SUBSTANTIVE AND PROCEDURAL NEVADA LAW TO ANY DISPUTE OR CLAIM, WITHOUT REFERENCE TO RULES OF CONFLICT OF LAW. TO THE EXTENT THAT THE JAMS RULES CONFLICT WITH NEVADA LAW, NEVADA LAW SHALL TAKE PRECEDENCE. CONSULTANT FURTHER AGREES THAT ANY ARBITRATION UNDER THIS AGREEMENT SHALL BE CONDUCTED IN NEVADA.
  
 C. Remedy. EXCEPT AS PROVIDED BY THE NRCP ACT AND THIS AGREEMENT, ARBITRATION SHALL BE THE SOLE, EXCLUSIVE, AND FINAL REMEDY FOR ANY DISPUTE BETWEEN CONSULTANT AND THE COMPANY. ACCORDINGLY, EXCEPT AS PROVIDED FOR BY THE NRCP ACT AND THIS AGREEMENT, NEITHER CONSULTANT NOR THE COMPANY WILL BE PERMITTED TO PURSUE COURT ACTION REGARDING CLAIMS THAT ARE SUBJECT TO ARBITRATION.
  
 D. Availability of Injunctive Relief. IN ACCORDANCE WITH THE NEVADA RULES OF CIVIL PROCEDURE, THE PARTIES AGREE THAT ANY PARTY MAY ALSO PETITION THE COURT FOR INJUNCTIVE RELIEF WHERE EITHER PARTY ALLEGES OR CLAIMS A VIOLATION OF ANY AGREEMENT REGARDING INTELLECTUAL PROPERTY, CONFIDENTIAL INFORMATION OR NONINTERFERENCE. IN THE EVENT EITHER PARTY SEEKS INJUNCTIVE RELIEF, THE PREVAILING PARTY SHALL BE ENTITLED TO RECOVER REASONABLE COSTS AND ATTORNEYS’ FEES.
  
 E. Administrative Relief. CONSULTANT UNDERSTANDS THAT EXCEPT AS PERMITTED BY LAW THIS AGREEMENT DOES NOT PROHIBIT CONSULTANT FROM PURSUING CERTAIN ADMINISTRATIVE CLAIMS WITH LOCAL, STATE OR FEDERAL ADMINISTRATIVE BODIES OR GOVERNMENT AGENCIES SUCH AS THE DEPARTMENT OF FAIR EMPLOYMENT AND HOUSING, THE EQUAL EMPLOYMENT OPPORTUNITY COMMISSION, THE NATIONAL LABOR RELATIONS BOARD, OR THE WORKERS’ COMPENSATION BOARD. THIS AGREEMENT DOES, HOWEVER, PRECLUDE CONSULTANT FROM BRINGING ANY ALLEGED WAGE CLAIMS WITH THE DEPARTMENT OF LABOR STANDARDS ENFORCEMENT. LIKEWISE, THIS AGREEMENT DOES PRECLUDE CONSULTANT FROM PURSUING COURT ACTION REGARDING ANY ADMINISTRATIVE CLAIMS, EXCEPT AS PERMITTED BY LAW.
  
 F. Voluntary Nature of Agreement. CONSULTANT ACKNOWLEDGES AND AGREES THAT CONSULTANT IS EXECUTING THIS AGREEMENT VOLUNTARILY AND WITHOUT ANY DURESS OR UNDUE INFLUENCE BY THE COMPANY OR ANYONE ELSE. CONSULTANT FURTHER ACKNOWLEDGES AND AGREES THAT CONSULTANT HAS CAREFULLY READ THIS AGREEMENT AND THAT CONSULTANT HAS ASKED ANY QUESTIONS NEEDED FOR CONSULTANT TO UNDERSTAND THE TERMS, CONSEQUENCES AND BINDING EFFECT OF THIS AGREEMENT AND FULLY UNDERSTAND IT, INCLUDING THAT CONSULTANT IS WAIVING CONSULTANT’S RIGHT TO A JURY TRIAL. FINALLY, CONSULTANT AGREES THAT CONSULTANT HAS BEEN PROVIDED AN OPPORTUNITY TO SEEK THE ADVICE OF AN ATTORNEY OF CONSULTANT’S CHOICE BEFORE SIGNING THIS AGREEMENT.
  
  	 
	-7-
	

	 

 
  
 12. Miscellaneous.
  
 A. Governing Law; Consent to Personal Jurisdiction. This Agreement shall be governed by the laws of the State of Nevada, without regard to the conflicts of law provisions of any jurisdiction. To the extent that any lawsuit is permitted under this Agreement, the Parties hereby expressly consent to the personal and exclusive jurisdiction and venue of the state and federal courts located in Nevada.
  
 B. Assignability. This Agreement will be binding upon Consultant’s heirs, executors, assigns, administrators, and other legal representatives, and will be for the benefit of the Company, its successors, and its assigns. There are no intended third-party beneficiaries to this Agreement, except as expressly stated. Except as may otherwise be provided in this Agreement, Consultant may not sell, assign or delegate any rights or obligations under this Agreement. Notwithstanding anything to the contrary herein, Company may assign this Agreement and its rights and obligations under this Agreement to any successor to all or substantially all of Company’s relevant assets, whether by merger, consolidation, reorganization, reincorporation, sale of assets or stock, change of control or otherwise.
  
 C. Entire Agreement. This Agreement constitutes the entire agreement and understanding between the Parties with respect to the subject matter herein and supersedes all prior written and oral agreements, discussions, or representations between the Parties. Consultant represents and warrants that Consultant is not relying on any statement or representation not contained in this Agreement. To the extent any terms set forth in any exhibit or schedule conflict with the terms set forth in this Agreement, the terms of this Agreement shall control unless otherwise expressly agreed by the Parties in such exhibit or schedule.
  
 D. Headings. Headings are used in this Agreement for reference only and shall not be considered when interpreting this Agreement.
  
 E. Severability. If a court or other body of competent jurisdiction finds, or the Parties mutually believe, any provision of this Agreement, or portion thereof, to be invalid or unenforceable, such provision will be enforced to the maximum extent permissible so as to effect the intent of the Parties, and the remainder of this Agreement will continue in full force and effect.
  
 F. Modification; Waiver. No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, will be effective unless in a writing signed by the Parties. Waiver by the Company of a breach of any provision of this Agreement will not operate as a waiver of any other or subsequent breach.
  
  	 
	-8-
	

	 

 
  
 G. Notices. Any notice or other communication required or permitted by this Agreement to be given to a Party shall be in writing and shall be deemed given (i) if delivered personally or by commercial messenger or courier service, (ii) when sent by confirmed facsimile, or (iii) if mailed by U.S. registered or certified mail (return receipt requested), to the Party at the Party’s address written below or at such other address as the Party may have previously specified by like notice. If by mail, delivery shall be deemed effective three business days after mailing in accordance with this Section 12.G.
  
 (1) If to the Company, to:
  
 711 S. Carson Street, Suite 4 
 Carson City, Nevada 89701 
 Attention: Chief Executive Officer
  
 (2) If to Consultant, to the address for notice on the signature page to this Agreement or, if no such address is provided, to the last address of Consultant provided by Consultant to the Company.
  
 H. Attorneys’ Fees. In any court action at law or equity that is brought by one of the Parties to this Agreement to enforce or interpret the provisions of this Agreement, the prevailing Party will be entitled to reasonable attorneys’ fees, in addition to any other relief to which that Party may be entitled.
  
 I. Signatures. This Agreement may be signed in two counterparts, each of which shall be deemed an original, with the same force and effectiveness as though executed in a single document.
  
 J. Applicability to Past Activities. Consultant agrees that if and to the extent that Consultant provided any services or made efforts on behalf of or for the benefit of Company, or related to the current or prospective business of Company in anticipation of Consultant’s involvement with the Company, that would have been “Services” if performed during the term of this Agreement (the “Prior Consulting Period”) and to the extent that during the Prior Consulting Period: (i) Consultant received access to any information from or on behalf of Company that would have been “Confidential Information” if Consultant received access to such information during the term of this Agreement; or (ii) Consultant (a) conceived, created, authored, invented, developed or reduced to practice any item (including any intellectual property rights with respect thereto) on behalf of or for the benefit of Company, or related to the current or prospective business of Company in anticipation of Consultant’s involvement with Company, that would have been an Invention if conceived, created, authored, invented, developed or reduced to practice during the term of this Agreement, or (b) incorporated into any such item any pre-existing invention, improvement, development, concept, discovery or other proprietary information that would have been a Prior Invention if incorporated into such item during the term of this Agreement; then any such information shall be deemed Confidential Information hereunder and any such item shall be deemed an Invention or Prior Invention hereunder, and this Agreement shall apply to such activities, information or item as if disclosed, conceived, created, authored, invented, developed or reduced to practice during the term of this Agreement. Consultant further acknowledges that Consultant has been fully compensated for all services provided during any such Prior Consulting Period.
  
  	 
	-9-
	

	 

 
  
 K. Protected Activity Not Prohibited. Consultant understands that nothing in this Agreement shall in any way limit or prohibit Consultant from engaging in any Protected Activity. For purposes of this Agreement, “Protected Activity” shall mean filing a charge, complaint, or report with, or otherwise communicating, cooperating, or participating in any investigation or proceeding that may be conducted by, any federal, state or local government agency or commission, including the Securities and Exchange Commission (“Government Agencies”). Consultant understands that in connection with such Protected Activity, Consultant is permitted to disclose documents or other information as permitted by law, and without giving notice to, or receiving authorization from, the Company. Notwithstanding the foregoing, Consultant agrees to take all reasonable precautions to prevent any unauthorized use or disclosure of any information that may constitute Company confidential information to any parties other than the Government Agencies. Consultant further understands that “Protected Activity” does not include the disclosure of any Company attorney-client privileged communications. Pursuant to the Defend Trade Secrets Act of 2016, Consultant is notified that an individual will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (i) is made in confidence to a federal, state, or local government official (directly or indirectly) or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if (and only if) such filing is made under seal. In addition, an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the individual’s attorney and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.
   
 (signature page follows)
  
  	 
	-10-
	

	 

 
  
 IN WITNESS WHEREOF, the Parties hereto have executed this Consulting Agreement as of the date first written above.
                 
  	 CONSULANT 
		 THE HEALING COMPANY, INC.
	
						
	 By
	 
		 By:
	 
	
						
	 Name: 
	 John Hoekman
		 Name: 
	 Simon Belsham
	
						
	 Title: 
	 Principal 
		 Title: 
	 CEO
	

 
   
 Address for Notice:
   
 	 162 East Elm Street, B2
	  

	  
	  

	 Greenwich, CT 06830
	  

	  
	  

	  
	  

 
 
   
  	 
	-11-
	

	 

 
  
 EXHIBIT A 
   
 SERVICES AND COMPENSATION
    
 1. Contact. Consultant’s principal Company contact: 
  
 Name: John Hoekman
  
 Title: Principal_________________________
  
 Email: jhoekman@umich.edu______________
  
 Phone: 917-747-3218____________________
  
 2. Services.
  
 Consultant is expected to provide approximately, but in no way as a limit, one to one and a half working days, or twelve (12) hours, per week during the Term. At the Company’s direction, Consultant will perform Services for the Company in collaboration with Company executives, including but not limited to:
  
 A. Supporting strategy for broader “closed-loop wellness” offerings beyond purely supplements, identifying the key elements that will create powerful habit + growth loops and potential buy/build strategies and sequences to architect them;
  
 B. Driving an integrated healing market landscape assessment, developing an overview of key players that could fulfill the core closed-loop wellness system elements defined above, identifying market standouts, high potentials, with key insights on why;
  
 C. Creating potential partnership models rooted in value creation for customer, the Company, and prospective partner, developing both strategic, operational, and financial considerations and expected return/benefits;
  
 D. Based on landscape assessment and potential partnership models, developing priority Company partnership and acquisition targets; and
  
 E. Driving partnership development with priority targets, spanning outreach, exploration, and negotiation, closing key targets.
  
 In addition, secondary duties:
  
 F. Supporting broader financing strategy and fundraising initiatives for the Company, including introductions to relevant investors, family offices on behalf of the Company;
  
 G. Helping the Company tell the Company’s story and opportunity, partnering with the marketing team to define and create content;
  
  	 
	-12-
	

	 

 
  
 H. Introductions to practitioners and subject matter expert connections for endorsements, content or fundraising; and
  
 I. Other services upon request of, and at the direction of, the Company’s Board of Directors of the Company (the “Board”) and CEO from time to time.
  
 3. Compensation.
  
 A. Cash Compensation. The Company will pay Consultant $5,000.00 per month, payable monthly in advance on the first day of each calendar month within five (5) days of the Company’s receipt of an invoice from Consultant. If Consultant works more than twelve (12) hours per week during the Term, Consultant and the Company shall mutually agree on a pro-rata increase in cash compensation payable hereunder.
  
 B. Equity Compensation. In further consideration of the Consultant’s provision of the Services, subject to approval by the Board, the Company shall grant to Consultant the options (the “Options”) to purchase up to 100,000 shares of Common Stock, at an exercise price per share equal to the greater of (1) the fair market value of a share of Common Stock of the Company at the time of such grant and (2) the price per share of Common Stock of the Company for shares purchased in the most recent round of equity financing, pursuant to terms to be set forth in the Company’s then-current Equity Incentive Plan (“Plan”) and a Non- Qualified Stock Option Award Agreement (“Award Agreement”). Each annual stock option grant (“Grant”) shall be pursuant to a separate Award Agreement. The Options shall vest in four (4) equal installments every three months during the Term and any Renewal Terms, provided that Consultant remains a Service Provider of the Company at the time of such vesting. The vesting start date shall begin on August 1, 2022, with the first installment of 25% of the Options vesting on the three-month anniversary thereof.
  
 C. Reimbursements. The Company will reimburse Consultant, in accordance with Company policy, for all reasonable expenses incurred by Consultant in performing the Services pursuant to this Agreement, if Consultant receives written consent from an authorized agent of the Company prior to incurring such expenses and submits receipts for such expenses to the Company in accordance with Company policy.
  
 Every month, beginning thirty (30) days from the Effective Date, Consultant shall submit to the Company a written invoice for expenses, and such statement shall be subject to the approval of the contact person listed above or other designated agent of the Company. The Company will remit payment for properly submitted and approved invoices within thirty (30) days following invoice submission. In order to help prevent adverse tax consequences to Consultant under Section 409A (as defined below), in no event will any payment under Section 3.A. of this Exhibit be made later than the later of March 15th of the calendar year following the calendar year in which such payment was earned.
  
 D. All payments and benefits provided for under this Agreement are intended to be exempt from or otherwise comply with the requirements of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations and guidance thereunder (together, “Section 409A”), so that none of the payments and benefits to be provided hereunder will be subject to the additional tax imposed under Section 409A, and any ambiguities or ambiguous terms herein will be interpreted to be exempt or so comply. Each payment and benefit payable under this Agreement is intended to constitute a separate payment for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations. In no event will the Company reimburse Consultant for any taxes that may be imposed on Consultant as a result of Section 409A.
  
  This Exhibit A is accepted and agreed upon as of  8/1/2022____________.      
   
  	 CONSULANT 
		 THE HEALING COMPANY, INC.
	
						
	 By
	 
		 By:
	 
	
						
	 Name: 
	 John Hoekman/RayRos 
		 Name: 
	 Simon Belsham
	
						
	 Title: 
	 Principal 
		 Title: 
	 CEO
	

 
   
  	 
	-13-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}]]